Estriol in Dogs

Estriol is a prescription estrogen medication used in dogs, most often to help control urine leakage in spayed females. In the United States, the labeled veterinary product is Incurin, and it is approved for estrogen-responsive urinary incontinence in ovariohysterectomized female dogs. In plain terms, that means it is used when a spayed dog leaks urine because the tissues and muscles around the urethra are not closing as tightly as they should.

Many dogs with this problem leak small amounts of urine while resting or sleeping. Medium and large spayed females are affected most often, but any dog with urinary leakage still needs a full workup because incontinence can also be linked to urinary tract infection, bladder stones, spinal disease, congenital problems, or other urinary disorders. Estriol can be very helpful in the right case, but it is not the right medication for every dog with accidents in the house.

One useful point for pet parents is that estriol is usually managed as a dose-to-effect medication. Your vet may start at a labeled dose, then step down over time to the lowest dose that still controls leakage. That approach can help maintain benefit while limiting estrogen-related side effects. Some dogs do well on estriol alone, while others may need a different medication or a combination plan.

Because estriol is a hormone, it should always be used under veterinary supervision. Your vet may recommend urine testing, bloodwork, and follow-up exams before and during treatment. That monitoring matters, especially if your dog has other health conditions or stays on the medication long term.

Estriol works by improving urethral closure pressure and resting tone in female dogs. The urethra is the tube that carries urine from the bladder to the outside. In some spayed dogs, lower estrogen levels after ovariohysterectomy are thought to contribute to weaker urethral tone, making leakage more likely when the dog is relaxed. Estriol binds to receptors in the lower urinary and reproductive tract and helps those tissues function more effectively.

This medication is absorbed after it is given by mouth, then processed by the liver and excreted in urine. Merck Veterinary Manual notes that estriol has an elimination half-life of about 8 to 12 hours in dogs. Even so, the clinical effect can be enough for once-daily dosing in many patients, especially once your vet identifies the lowest effective maintenance dose.

Estriol does not treat every cause of incontinence. It is most useful when your vet suspects urethral sphincter mechanism incompetence, sometimes called spay incontinence or hormone-responsive incontinence. If the real problem is a urinary tract infection, bladder stone, ectopic ureter, neurologic disease, or severe bladder dysfunction, estriol alone may not help much.

Some dogs respond better to a different medication, such as phenylpropanolamine, which increases urethral tone through a different pathway. In certain cases, your vet may discuss using one medication first, switching medications, or combining options if leakage is not well controlled.

Estriol is often well tolerated, but side effects can happen, especially at higher doses. Reported effects include decreased appetite, vomiting, increased thirst, lethargy, anxiety, aggression, hypersalivation, swollen vulva, signs that resemble heat behavior, sexual attractiveness to male dogs, and mammary enlargement. These estrogenic effects often improve when the dose is lowered, which is one reason vets try to find the lowest effective dose.

Pet parents should also know that any dog with new or worsening urinary signs while taking estriol still needs re-evaluation. Leakage that returns can mean the dose needs adjustment, but it can also point to a urinary tract infection, bladder disease, or another condition that needs separate treatment. If your dog seems weak, very tired, stops eating, or develops unusual bruising or bleeding, contact your vet promptly.

Older estrogen drugs have been associated with bone marrow suppression, including serious blood cell problems. Estriol appears to have a lower risk profile than older compounds such as diethylstilbestrol, and FDA safety data for Incurin did not show estriol-related bone marrow changes in the target animal safety study. Even so, VCA recommends baseline testing and periodic complete blood counts for dogs on long-term therapy, which is a practical safeguard.

Estriol should not be used in pregnant or lactating dogs, in dogs younger than 1 year, or alongside other estrogens unless your vet has a very specific reason. Dogs with polyuria and polydipsia, meaning increased urination and increased drinking, may not be good candidates until the underlying cause is sorted out.

Estriol dosing should come directly from your vet, because the right dose depends on your dog’s diagnosis, response, and side effects. For the FDA-approved canine product Incurin, the usual labeled starting dose is 2 mg by mouth once daily. After urinary leakage is controlled, your vet typically reduces the dose stepwise to find the lowest effective dose.

Common step-down options described in the product information include 2 mg once daily, then 1 mg once daily, then 0.5 mg once daily, with at least 7 days between dose adjustments. FDA approval documents also describe that once the lowest daily dose is identified, some dogs may be maintained on dosing every other day. Dogs should not receive more than 2 mg per day, and if a dog does not respond at that dose, your vet should reassess the diagnosis rather than keep increasing the medication.

Estriol can generally be given with or without food. If stomach upset happens, your vet may suggest giving it with a meal. Try to give the medication consistently and avoid changing the dose on your own. If you miss a dose, contact your vet or pharmacist for guidance rather than doubling the next dose.

Monitoring is part of safe administration. VCA recommends baseline bloodwork and urinalysis before starting estriol, then a complete blood count 2 to 4 weeks after starting long-term therapy and every 3 to 6 months after that. Your vet may also want urine testing or recheck visits to confirm that the leakage is truly hormone responsive and that no new urinary problem has developed.

Estriol should not be combined with other estrogen products unless your vet specifically directs it. Using multiple estrogenic medications together can raise the risk of hormone-related side effects. That includes prescription estrogens and some compounded hormone products.

Your vet will also want a full medication and supplement list before prescribing estriol. While published veterinary interaction data are not as extensive as they are for some other drugs, any medication that affects hormone balance, liver metabolism, or urinary function may matter in an individual dog. This is especially true in senior dogs that are already taking several medications.

If your dog is being treated for urinary leakage, your vet may compare estriol with phenylpropanolamine or discuss combination therapy in selected cases. These drugs work differently, so the choice depends on your dog’s exam findings, blood pressure, urinary testing, and side effect history. Combination plans can be useful for some dogs, but they should be monitored rather than improvised at home.

Tell your vet if your dog has a history of mammary disease, reproductive tract disease, liver disease, unusual bleeding, or increased drinking and urination. Those details may change whether estriol is a good fit, whether more testing is needed first, or whether another treatment path makes more sense.